Integra Lifesciences Holdings Corp
IART
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.31B
Close$
$31.51
91.7% upside
Current Fair Value
91.7% upsideUndervalued by 91.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.31 Billion |
|---|---|
| Enterprise Value | $3.15 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.73 |
| Beta | 1.21 |
| Outstanding Shares | 78,168,000 |
Return
| Return on Equity | -0.69% |
|---|---|
| Return on Assets | -0.20% |
| Return on Invested Capital | 3.32% |
Valuation & Multiples
| P/E Ratio | -183.19 |
|---|---|
| PEG | 181.51 |
| Price to Sales | 0.78 |
| Price to Book Ratio | 1.26 |
| Enterprise Value to Revenue | 1.91 |
| Enterprise Value to EBIT | 29.29 |
| Enterprise Value to Net Income | -435 |
| Total Debt to Enterprise | 0.65 |
| Debt to Equity | 1.95 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.48
Average shareholder expectationRevenue Estimate
$417.62 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.56
Average shareholder expectationRevenue Estimate
$416.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 98.75%▲ 1.30% |
|---|---|
| Total Invested | $1.42B▲ 100.87% |
| Investors Holding | 212▲ 10.00% |
ESG Score
No data
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini